ELV - Elevance Health Inc

ELV - Elevance Health Inc

https://www.elevancehealth.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

New Strong Sell Stocks for September 15th

Zacks Commentary • 5 hours, 31 minutes ago • score: 0.08

CE, ELV and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2025.

Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?

Zacks Commentary • 3 days, 2 hours ago • score: 0.16

ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.

New Strong Sell Stocks for September 11th

Zacks Commentary • 4 days, 6 hours ago • score: 0.07

REFI, ELV and TAP have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2025.

Elevance Health's Options: A Look at What the Big Money is Thinking - Elevance Health ( NYSE:ELV )

Benzinga • 5 days, 20 hours ago • score: 0.26

Investors with a lot of money to spend have taken a bullish stance on Elevance Health ELV. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

52W High

$552.90

52W Low

$273.71

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.60

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

13.32

Forward P/E (<15 better)

9.55

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

0.49

P/S (TTM) (<3 favorable)

0.37

P/B (<3 favorable)

1.62

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.17%

Institutions (25–75% balanced)

93.26%

Shares Outstanding

225,178,000

Float

224,665,000

Dividend Yield (2–6% sweet spot)

0.02%

Ex‑Dividend Date

2025-09-10

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

189,253,992,000

Gross Profit (TTM)

50,787,000,000

EPS (TTM)

23.55

Profit Margin (>10% good)

0.03%

Operating Margin (TTM) (higher better)

0.05%

ROE (TTM) (>15% strong)

0.12%

EPS YoY (Quarterly) (>10% good)

-0.22

Revenue YoY (Quarterly) (>8% good)

0.14

Momentum

Bearish momentum

Value

2.1190

Previous

2.2084

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025